Why the study?
Cardiac arrhythmias are common in pregnancy, requiring careful consideration of the risks and benefits of antiarrhythmic drugs and other treatment options.
This review outlines the diagnosis and management of cardiac arrhythmias in pregnancy, emphasizing that while arrhythmias are common, treatment must carefully balance maternal benefit with fetal safety.
Answers are grounded in this paper and cite their sources.
Arrhythmia management in pregnancy demands individualized risk-benefit analysis; leaves open prospective trials on intervention safety.
Cardiac arrhythmias are common in pregnancy. The approach to the diagnosis of arrhythmias in pregnancy requires a detailed clinical history and examination and documentation of the arrhythmia preferably on a Holter or electrocardiogram. Treatment of arrhythmias is arrhythmia specific and may require antiarrhythmic drug therapy. However, the risks and benefits of antiarrhythmic drugs must be carefully considered. Catheter ablation remains a treatment option but is seldom required during pregnancy.
No takes yet. Share an insight, caveat, or question.
Mkoko et al. (2022) conducted a review in Cardiac arrhythmias in pregnancy. Antiarrhythmic drugs, direct current cardioversion, and catheter ablation was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: